Tram Anh Nguyen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tram Anh Nguyen has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Eng Piew Louis Kok
Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore
2 shared publicationsHao Liu
School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, Singapore
2 shared publications- Meng How Tan
Nanyang Technological University
2 shared publications Yuanming Wang
School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, Singapore
2 shared publications- Yue Wan
Stem Cell and Regenerative Biology, Genome Institute of Singapore, A*STAR, Singapore, Singapore
2 shared publications Zirong Yi
School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, Singapore
2 shared publications
Latest Publications
- Open Access
DRIVE-KG: Enhancing variant-phenotype association discovery in understudied complex diseases using heterogeneous knowledge graphs
Multi-omics data are instrumental in obtaining a comprehensive picture of complex biological systems. This is particularly useful for women’s health conditions, such as endometriosis which has been historically understudied despite having a high prevalence (around 10% of women of reproductive age). Subsequently, endometriosis has limited genetic characterization: current genome-wide association studies explain only 11% of its 47% total estimated heritability. Graph representations provide an intuitive and meaningful way to relate concepts across diverse data sources and address fundamental sparsity and dimensionality challenges with multi-omics data analysis. Here we present DRIVE-KG (Disease Risk Inference and Variant Exploration-Knowledge Graph), which uses a heterogeneous graph representation to integrate biological data from multi-omics datasets: dbSNP, NCBI Human Gene, Omics Pred, GTEx, and Open Targets. We drew directly from the knowledge captured in these data, using nodes to represent genes, single nucleotide polymorphisms, proteins, and phenotypes, and edges to represent relationships between these concepts. We trained two models using DRIVE-KG: a link prediction model to suggest associations between SNPs and two pilot phenotypes (endometriosis and obesity), and a graph convolutional network (GCN) to classify patient-level endometriosis status. We conducted the patient-level classification using data from 1,441 Penn Medicine BioBank participants with gold standard chart-reviewed endometriosis status. The link prediction model uncovered 66 high-confidence (score ≥ 0.95) previously unreported SNP-endometriosis associations. Many of these variants were linked to obesity/body mass index traits (24.2%), lipid metabolism (6%), and depressive disorders (4.5%), showing agreement with emerging hypotheses about endometriosis etiology. In contrast, 11% of the 149 high confidence, candidate SNP-obesity associations (score ≥ 0.9888) were in LD with known obesity associations. The GCN to classify patient endometriosis status had an AUPRC of 0.738 compared to 0.679 for a genetic risk score. Despite this moderate improvement, we found that the GCN learned meaningful stratification of underlying adenomyosis signal and severe grades of endometriosis. We have demonstrated that heterogeneous integration of multi-omics data is valuable for diverse downstream tasks—including discovery and clinical prediction—particularly for understudied diseases where traditional genomic approaches are insufficient.
Open AccessDRIVE-KG: Enhancing variant-phenotype association discovery in understudied complex diseases using heterogeneous knowledge graphs
Multi-omics data are instrumental in obtaining a comprehensive picture of complex biological systems. This is particularly useful for women’s health conditions, such as endometriosis which has been historically understudied despite having a high prevalence (around 10% of women of reproductive age). Subsequently, endometriosis has limited genetic characterization: current genome-wide association studies explain only 11% of its 47% total estimated heritability. Graph representations provide an intuitive and meaningful way to relate concepts across diverse data sources and address fundamental sparsity and dimensionality challenges with multi-omics data analysis. Here we present DRIVE-KG (Disease Risk Inference and Variant Exploration-Knowledge Graph), which uses a heterogeneous graph representation to integrate biological data from multi-omics datasets: dbSNP, NCBI Human Gene, Omics Pred, GTEx, and Open Targets. We drew directly from the knowledge captured in these data, using nodes to represent genes, single nucleotide polymorphisms, proteins, and phenotypes, and edges to represent relationships between these concepts. We trained two models using DRIVE-KG: a link prediction model to suggest associations between SNPs and two pilot phenotypes (endometriosis and obesity), and a graph convolutional network (GCN) to classify patient-level endometriosis status. We conducted the patient-level classification using data from 1,441 Penn Medicine BioBank participants with gold standard chart-reviewed endometriosis status. The link prediction model uncovered 66 high-confidence (score ≥ 0.95) previously unreported SNP-endometriosis associations. Many of these variants were linked to obesity/body mass index traits (24.2%), lipid metabolism (6%), and depressive disorders (4.5%), showing agreement with emerging hypotheses about endometriosis etiology. In contrast, 11% of the 149 high confidence, candidate SNP-obesity associations (score ≥ 0.9888) were in LD with known obesity associations. The GCN to classify patient endometriosis status had an AUPRC of 0.738 compared to 0.679 for a genetic risk score. Despite this moderate improvement, we found that the GCN learned meaningful stratification of underlying adenomyosis signal and severe grades of endometriosis. We have demonstrated that heterogeneous integration of multi-omics data is valuable for diverse downstream tasks—including discovery and clinical prediction—particularly for understudied diseases where traditional genomic approaches are insufficient.
- 9 October 2024
- Published by Springer Nature in Nature Biotechnology
- p. 1-14
A circularly permuted CasRx platform for efficient, site-specific RNA editing
Inactive Cas13 orthologs have been fused to a mutant human ADAR2 deaminase domain at the C terminus to enable programmable adenosine-to-inosine (A-to-I) RNA editing in selected transcripts. Although promising, existing RNA-editing tools generally suffer from a trade-off between efficacy and specificity, and off-target editing remains an unsolved problem. Here we describe the development of an optimized RNA-editing platform by rational protein engineering, CasRx-based Programmable Editing of RNA Technology (xPERT). We demonstrate that the topological rearrangement of a CasRx K940L mutant by circular permutation results in a robust scaffold for the tethering of a deaminase domain. We benchmark our tool against the REPAIR system and show that xPERT exhibits strong on-target activity like REPAIRv1 but low off-target editing like REPAIRv2. Our xPERT platform can be used to alter RNA sequence information without risking genome damage, effect temporary cellular changes and customize protein function.
- 9 October 2024
- Published by Springer Nature in Nature Biotechnology
- p. 1-14
A circularly permuted CasRx platform for efficient, site-specific RNA editing
Inactive Cas13 orthologs have been fused to a mutant human ADAR2 deaminase domain at the C terminus to enable programmable adenosine-to-inosine (A-to-I) RNA editing in selected transcripts. Although promising, existing RNA-editing tools generally suffer from a trade-off between efficacy and specificity, and off-target editing remains an unsolved problem. Here we describe the development of an optimized RNA-editing platform by rational protein engineering, CasRx-based Programmable Editing of RNA Technology (xPERT). We demonstrate that the topological rearrangement of a CasRx K940L mutant by circular permutation results in a robust scaffold for the tethering of a deaminase domain. We benchmark our tool against the REPAIR system and show that xPERT exhibits strong on-target activity like REPAIRv1 but low off-target editing like REPAIRv2. Our xPERT platform can be used to alter RNA sequence information without risking genome damage, effect temporary cellular changes and customize protein function.
- 13 June 2022
- Published by Springer Nature in Nature Methods
- Vol. 19 (7) , 833-844
Direct identification of A-to-I editing sites with nanopore native RNA sequencing
Inosine is a prevalent RNA modification in animals and is formed when an adenosine is deaminated by the ADAR family of enzymes. Traditionally, inosines are identified indirectly as variants from Illumina RNA-sequencing data because they are interpreted as guanosines by cellular machineries. However, this indirect method performs poorly in protein-coding regions where exons are typically short, in non-model organisms with sparsely annotated single-nucleotide polymorphisms, or in disease contexts where unknown DNA mutations are pervasive. Here, we show that Oxford Nanopore direct RNA sequencing can be used to identify inosine-containing sites in native transcriptomes with high accuracy. We trained convolutional neural network models to distinguish inosine from adenosine and guanosine, and to estimate the modification rate at each editing site. Furthermore, we demonstrated their utility on the transcriptomes of human, mouse and Xenopus. Our approach expands the toolkit for studying adenosine-to-inosine editing and can be further extended to investigate other RNA modifications.
- 13 June 2022
- Published by Springer Nature in Nature Methods
- Vol. 19 (7) , 833-844
Direct identification of A-to-I editing sites with nanopore native RNA sequencing
Inosine is a prevalent RNA modification in animals and is formed when an adenosine is deaminated by the ADAR family of enzymes. Traditionally, inosines are identified indirectly as variants from Illumina RNA-sequencing data because they are interpreted as guanosines by cellular machineries. However, this indirect method performs poorly in protein-coding regions where exons are typically short, in non-model organisms with sparsely annotated single-nucleotide polymorphisms, or in disease contexts where unknown DNA mutations are pervasive. Here, we show that Oxford Nanopore direct RNA sequencing can be used to identify inosine-containing sites in native transcriptomes with high accuracy. We trained convolutional neural network models to distinguish inosine from adenosine and guanosine, and to estimate the modification rate at each editing site. Furthermore, we demonstrated their utility on the transcriptomes of human, mouse and Xenopus. Our approach expands the toolkit for studying adenosine-to-inosine editing and can be further extended to investigate other RNA modifications.
- Open Access
- 23 November 2019
- Published by Elsevier in Aquaculture
- Vol. 519, 734765
Collective action governance and benefits distribution in the sturgeon value chain in Lâm Đồng province, Vietnam
- 23 November 2019
- Published by Elsevier in Aquaculture
- Vol. 519, 734765
Open AccessCollective action governance and benefits distribution in the sturgeon value chain in Lâm Đồng province, Vietnam